Loss of heterozygosity in neuroblastomas - An overview

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 1971-1973

  Takita, J ^a,b   Hayashi, Y ^b   Yokota, J ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

9p LOH; Allelotype; Neuroblastoma

Indexed keywords

ALLELE; CANCER SCREENING; CHROMOSOME LOSS; CONFERENCE PAPER; GENE AMPLIFICATION; GENE DELETION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; NEUROBLASTOMA; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; X CHROMOSOME;

CHROMOSOMES, HUMAN; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; NEUROBLASTOMA; RISK FACTORS;

EID: 0031418050     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00292-X     Document Type: Conference Paper

References (28)

1. Tsuda T, Obara M, Hirano H, et al. Analysis of N-myc amplification in relation to disease stage and histology types in human neuroblastoma. Am J Pathol 1987, 136, 1043-1052.
2. Hayashi Y, Kanda N, Inaba T, et al. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 1989, 63, 126-132.
3. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984, 224, 1121-1124.
4. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313, 1111-1116.
5. Cohn SL, Look AT, Joshi VV, et al. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group Study. Cancer Res 1995, 55, 721-726.
6. Lee WH, Bookstein R, Hong F, et al. Human retinoblastoma susceptibility gene: cloning identification, and sequence. Science 1987, 235, 1394-1399.
7. Nakamura T, Iwamura Y, Kaneko M, et al. Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors. Jpn J Clin Oncol 1991, 21, 325-329.
8. Immamura J, Bartran CR, Berthold F, et al. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res 1993, 53, 4053-4058.
9. The I, Murthy AE, Hanningan GE, et al. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nature Genet 1993, 3, 62-66.
10. Vogan K, Berstein, M, Lecler J-M, et al. Absence of p53 gene mutations in primary neuroblastoma. Cancer Res 1993, 53, 5269-5273.
11. Kamb A, Gruis NA, Weaver-Feldhous J, et al. A Cell cycle regulator potentially involved in genesis of many tumor types. Science 1994, 264, 436-438.
12. Beltinger CP, White PS, Sulman EP, et al. No CDKN2 mutation in neuroblastomas. Cancer Res 1995, 55, 2053-2055.
13. Fong CT, Dracopoli NC, White PS, et al. Loss of heterozygosity for the short chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 1989, 86, 3753-3757.
14. Suzuki T, Yokota J, Mugishima H, et al. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 1989, 49, 1095-1098.
15. Fong CT, White PS, Peterson K, et al. Loss of heterozygosity for chromosome 1 or 14 defines subsets of advanced neuroblastoma. Cancer Res 1992, 52, 1780-1785.
16. Takayama H, Suzuki T, Mugishima H, et al. Deletion map of chromosome 14q in neuroblastoma. Oncogene 1992, 7, 1185-1189.
17. Caron H, van Sluis P, van Hoeve M, et al. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genet 1993, 4, 187-190.
18. Srivatsan E. S., Ying K. L., Seeger R. C. Deletion of chromosome 11 and 14q sequences in neuroblastoma. Genes Chrom Cancer. 7:1993;32-37.
19. Schleiermacher G, Peter M, Michon J, et al. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chrom Cancer 1994, 10, 275-281.
20. Takeda O, Homma C, Maseki K, et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtype of neuroblastoma. Genes Chrom Cancer 1994, 10, 30-39.
21. Takita J., Hayashi Y., Kohno T., et al. Allelotype of neuroblastoma. Oncogene. 11:1995;1829-1834.
22. Kohno T, Morishita K, Takano H, et al. Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. Oncogene 1994, 9, 103-108.
23. Nobori T, Miura K, Wu DJ, et al. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature (Lond) 1994, 368, 753-756.
24. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond). 371:1994;257-261.
25. Jen J, Harper JW, Bigner SH, et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1995, 54, 6353-6358.
26. INK4B/MTS2 and p18 genes in primary and metastatic lung cancer. Cancer Res 1995, 55, 1448-1451.
27. Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is alterated in colorectal cancer. Science 1990, 247, 49-56.
28. Lawlor K. G., Narayanan R. Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. Cell Growth Differ. 3:1992;609-616.